Neuromuscular disease Male PABPN1 Animals Aging Therapy COVID-19 Cytoskeleton Dermatomyositis RNA interference Motoneuron Autoimmunity Myogenesis Lamin A/C Myasthenia Gravis MG Gene therapy Becker muscular dystrophy Genetics Biomarkers Mice Rare diseases Myotonic dystrophy Laminopathy Actin Myopathy Autophagy Congenital myopathy Myositis Biomarker CRISPRi Inflammation Laminopathie Long read sequencing Satellite cell Myotonic dystrophy type 1 Mechanotransduction Brain Outcome measures Errance diagnostique Regeneration Trinucleotide repeat expansion Treatment Humans AAV Lamin A/C LMNA gene Fibrosis Dystrophin RNA biology Cardiomyopathy Muscle regeneration Rare neuromuscular diseases Cell therapy ALS Heart Dilated cardiomyopathy Cytokines DMD Satellite cells Myoblasts LMNA Thymus Neuromuscular diseases Genotype phenotype correlation Fabry disease Alternative splicing Aged MBNL Myotonic Dystrophy Autoantibodies Skeletal muscle Thérapie génique Duchenne muscular dystrophy Centronuclear myopathy LMNA gene Calcium Nuclear envelope Laminopathies Dynamin 2 Muscular dystrophy CMS Heart failure Spinal muscular atrophy OPMD Myopathies Glutamate CTG repeat contractions Myotonic Dystrophy type 1 Neuromuscular junction FSHD Transgenic mouse model Autoimmune diseases Transcriptomics Astrocyte Antisense oligonucleotides Mouse model Exercise Amyotrophic lateral sclerosis Congenital muscular dystrophy Muscle Myasthenia gravis